Sinew Pharma, Inc. stock analysis
Sinew Pharma, Inc. (6634) Stock Price & Analysis
6634 Stock Chart & Stats
- Day’s Range
- TWD 56.00 - TWD 64.90
- 52-Week Range
- TWD 29.05 - TWD 85.00
- Previous Close
- TWD 57.20
- Volume
- N/A
- Average Volume (3M)
- 88.44K
- Market Cap
- TWD 4.08B
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- TWD 995.27M
- Total Debt (Recent Filing)
- TWD 12.27M
- Price to Earnings (P/E)
- ―
- Beta
- 0.43
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
6634 FAQ
What was Sinew Pharma, Inc.’s price range in the past 12 months?
What is Sinew Pharma, Inc.’s market cap?
When is Sinew Pharma, Inc.’s upcoming earnings report date?
Is Sinew Pharma, Inc. overvalued?
Does Sinew Pharma, Inc. pay dividends?
What is Sinew Pharma, Inc.’s EPS estimate?
How many shares outstanding does Sinew Pharma, Inc. have?
Which hedge fund is a major shareholder of Sinew Pharma, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Sinew Pharma, Inc.
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Kai-Min Chu
- Employees
- 52
- Website
- www.sinewpharma.com
- Address
- C516, Building C, Taipei, TP, 11571, TW
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 5 | 6 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 8 | 0 | 4 |

